These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 38003712)
1. Cannabinoids and Their Receptors in Skin Diseases. Yoo EH; Lee JH Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003712 [TBL] [Abstract][Full Text] [Related]
2. The potential role of cannabinoids in dermatology. Sheriff T; Lin MJ; Dubin D; Khorasani H J Dermatolog Treat; 2020 Dec; 31(8):839-845. PubMed ID: 31599175 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases. Ramer R; Hinz B Cells; 2022 Dec; 11(24):. PubMed ID: 36552866 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoids for skin diseases and hair regrowth. Gupta AK; Talukder M J Cosmet Dermatol; 2021 Sep; 20(9):2703-2711. PubMed ID: 34363728 [TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Bíró T; Tóth BI; Haskó G; Paus R; Pacher P Trends Pharmacol Sci; 2009 Aug; 30(8):411-20. PubMed ID: 19608284 [TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. Río CD; Millán E; García V; Appendino G; DeMesa J; Muñoz E Biochem Pharmacol; 2018 Nov; 157():122-133. PubMed ID: 30138623 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review. Kuzumi A; Yamashita T; Fukasawa T; Yoshizaki-Ogawa A; Sato S; Yoshizaki A Exp Dermatol; 2024 Mar; 33(3):e15064. PubMed ID: 38532572 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoids for the treatment of chronic pruritus: A review. Avila C; Massick S; Kaffenberger BH; Kwatra SG; Bechtel M J Am Acad Dermatol; 2020 May; 82(5):1205-1212. PubMed ID: 31987788 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. Davis MP Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System. Tóth KF; Ádám D; Bíró T; Oláh A Molecules; 2019 Mar; 24(5):. PubMed ID: 30845666 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoids and Pain: Sites and Mechanisms of Action. Starowicz K; Finn DP Adv Pharmacol; 2017; 80():437-475. PubMed ID: 28826543 [TBL] [Abstract][Full Text] [Related]
13. Examining the role of cannabinoids on osteoporosis: a review. Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719 [TBL] [Abstract][Full Text] [Related]
14. Basic neuroanatomy and neuropharmacology of cannabinoids. Breivogel CS; Sim-Selley LJ Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505 [TBL] [Abstract][Full Text] [Related]
17. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review. Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders. Baswan SM; Klosner AE; Glynn K; Rajgopal A; Malik K; Yim S; Stern N Clin Cosmet Investig Dermatol; 2020; 13():927-942. PubMed ID: 33335413 [TBL] [Abstract][Full Text] [Related]
19. The role of cannabinoids in dermatology. Mounessa JS; Siegel JA; Dunnick CA; Dellavalle RP J Am Acad Dermatol; 2017 Jul; 77(1):188-190. PubMed ID: 28416341 [No Abstract] [Full Text] [Related]
20. Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues. Vecchini Rodríguez CM; Escalona Meléndez Y; Flores-Otero J Adv Exp Med Biol; 2021; 1297():43-64. PubMed ID: 33537936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]